TIF1γ interferes with TGFβ1/SMAD4 signaling to promote poor outcome in operable breast cancer patients

BACKGROUND: The Transforming growth factor β (TGFβ) signaling has a paradoxical role in cancer development and outcome. Besides, the prognostic significance of the TGFβ1, SMAD4 in breast cancer patients is an area of many contradictions. The transcriptional intermediary factor 1γ (TIF1γ) is thought...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:BMC Cancer
Egile Nagusiak: Kassem, Loay, Deygas, Mathieu, Fattet, Laurent, Lopez, Jonathan, Goulvent, Thibaut, Lavergne, Emilie, Chabaud, Sylvie, Carrabin, Nicolas, Chopin, Nicolas, Bachelot, Thomas, Gillet, Germain, Treilleux, Isabelle, Rimokh, Ruth
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2015
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4453047/
https://ncbi.nlm.nih.gov/pubmed/26040677
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-015-1471-y
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak